Mag Pharma Private Limited

Mag Pharma Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2008PTC179172 Incorporated 06 June 2008 ROC Delhi HQ Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹4.87 Cr
▲ 6% YoY
Net profit · FY 2025
₹4.8 Lakh
Net margin 1%
EBITDA · FY 2025
₹6.7 Lakh
EBITDA margin 1.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹6.5 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Mag Pharma Private Limited

Data last updated:

Mag Pharma Private Limited is a private limited company based in Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 06 June 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2008PTC179172. Its GSTIN is 27AAFCM6153J1Z8 (Maharashtra).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6.5 Lakh. It is led by directors including Farhana Kausar Usmani and Kausar Parveen.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 7144 Beri Wala Bagh Pul Bangash Azad Market, Delhi, India – 110006.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.87 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹4.8 Lakh (net margin 1%) and EBITDA of ₹6.7 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51397DL2008PTC179172
Registration Number 179172
Incorporation Date 06 June 2008
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Mag Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    7144 Beri Wala Bagh Pul Bangash Azad Market, Delhi, India – 110006
  • Industry
    Healthcare, Ayurvedic Products & Services

To see the full contact details of Mag Pharma Private Limited, buy the company report.

Comprehensive company report
Mag Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mag Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Mag Pharma Private Limited, buy the company report.

Financials of Mag Pharma Private Limited

FY 2025 filings available

Mag Pharma Private Limited reported revenue of ₹4.87 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹4.87 Cr ▲ 6%
Net profit · FY 2025
₹4.8 Lakh margin 1%
EBITDA · FY 2025
₹6.7 Lakh margin 1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 5%
5 years · compounded
▲ 5%

Revenue has grown at a compounded annual rate (CAGR) of 3% over three years, including 6% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.7 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4.8 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin1.4%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mag Pharma Private Limited, buy the company report.

Board of directors of Mag Pharma Private Limited

Mag Pharma has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Farhana Kausar UsmaniDirector06 Jun 200818 Years 4 MonthsCurrent
Kausar ParveenDirector01 Jul 20224 Years 3 MonthsCurrent
Danish KhanDirector30 Sep 20215 Years 0 MonthsCurrent
Mohd Ali KhanDirector30 Sep 20215 Years 0 MonthsCurrent
Mohammad Faisal Saleem AhmadDirector29 Jul 20251 Years 2 MonthsCurrent

Peer comparison

Mag Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Caventis Pharma Private Limited₹4.88 Cr (FY 2024)-11.0%Delhi, India
Mag Pharma Private Limited this company₹4.87 Cr (FY 2025)₹4.8 Lakh1%6.0%Delhi, India
Aarier Pharma Private Limited₹4.85 Cr (FY 2025)109.0%Mumbai, Maharashtra, India
Exhar Formulations Private Limited₹4.84 Cr (FY 2020)21.0%New Delhi, Delhi, India

To see the full peer comparison of Mag Pharma Private Limited, buy the company report.

Auditor

Mag Pharma Private Limited is audited by ASLAM JAVED & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
ASLAM JAVED & COFY 2022016224N

Shareholding

The shareholding of Mag Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Mag Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Mag Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Mag Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAFCM6153J1Z8MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Mag Pharma Private Limited, buy the company report.

Recent activity

Mag Pharma Private Limited has 19 board changes on record since 2008: 12 appointments and 7 cessations. The latest: Hussain ceased to be Director on 29 Jul 2025.

AGM
Mag Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Hussain ceased to be Director.
Appointed
Mohammad Faisal Saleem Ahmad was appointed as Director.
Filing
Mag Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Kausar Parveen was appointed as Director.
Appointed
Hussain was appointed as Director.
Ceased
Tanzeem Ahmad ceased to be Additional Director.
Ceased
Mohd Asim ceased to be Director.
Ceased
Aarifa ceased to be Director.
Appointed
Aarifa was appointed as Director.
Appointed
Danish Khan was appointed as Director.
Appointed
Mohd Ali Khan was appointed as Director.

10 earlier events are in the company report.

Frequently asked questions

Mag Pharma is an active private limited company based in Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 06 June 2008 (18+ years old) and is registered under CIN U51397DL2008PTC179172.

Mag Pharma has 5 current directors:

The latest financial statements of Mag Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Mag Pharma is 27AAFCM6153J1Z8, registered in Maharashtra.

The CIN (Corporate Identification Number) of Mag Pharma is U51397DL2008PTC179172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mag Pharma was incorporated on 06 June 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Mag Pharma by revenue are Caventis Pharma Private Limited, Aarier Pharma Private Limited, Exhar Formulations Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Hussain ceased to be Director on 29 Jul 2025. Mohammad Faisal Saleem Ahmad was appointed as Director on 29 Jul 2025. Kausar Parveen was appointed as Director on 01 Jul 2022. Mag Pharma has 19 board changes on record in total.

The registered office of Mag Pharma is at 7144 Beri Wala Bagh Pul Bangash Azad Market, Delhi, India – 110006.

Mag Pharma operates in the healthcare industry, in the ayurvedic products and services segment.

The compliance status of Mag Pharma is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.